Denis Granados

Head of pharmacoepidemiology General Medicine GBU
Sanofi, France

Poster(s):

• (X) Structured Benefit-Risk for Enoxaparin Based on Real World Evidence Data in The Context of Its Label Extension for Treatment of Deep Vein Thrombosis and Pulmonary Embolism and Prevention of Its Recurrence in Active Cancer Patients
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST